TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AGEN

Agenus Inc

Healthcare · Biotechnology

7.20$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Agenus Inc (AGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 114 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7.0 25 23 43 37 150 88 296 98 156 103 114
22 70 95 116 125 168 145 182 197 238 156 80
-15 -46 -72 -73 -88 -18 -57 114 -99 -81 -53 34
22 70 95 116 125 168 143 179 17 235 156 79
21 28 33 34 37 46 59 76 81 79 72 54
21 28 33 34 37 52 60 88 80 78 68 54
-43 -81 -107 -104 -124 -70 -117 26 -179 -160 -120 -21
1.3 6.6 17 19 25 41 61 66 62 98 118 55
-42 -88 -127 -121 -162 -112 -183 -29 -231 -257 -232 -3.1
5.1 -5.4 -3.0 -9.2 -13 38 57 66 41 -12
-42 -88 -127 -121 -160 -108 -181 -24 -220 -246 -227 0.1
-40 -85 -105 -96 -130 -63 -115 44 -162 -146 -101 62

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?